GlassScriptPhysician profile
Tracy J Moll
NPI 1427430396
$2,362.39
in general payments reported to CMS, 2019-2025
19 companies · $938 in 2025
The $938 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $86.19 · 2021: $159 · 2022: $334 · 2023: $322 · 2024: $309 · 2025: $938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $753 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $600 · Travel and Lodging: $130 · Education: $85.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $752.69 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $600.00 |
| Travel and Lodging | $129.94 |
| Education | $85.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beckman Coulter, INC. | $837.42 | 2025 | |
| Biogen, INC. | $174.09 | 2021-2023 | Vumerity |
| Alexion Pharmaceuticals, INC. | $152.21 | 2023-2024 | Ultomiris |
| Genzyme Corporation | $138.67 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $125.00 | 2022 | |
| Amneal Pharmaceuticals LLC | $100.29 | 2025 | Crexont |
| Amgen INC. | $99.99 | 2022 | |
| Lundbeck LLC | $91.67 | 2024 | Vyepti |
| Biohaven Pharmaceuticals, INC. | $84.73 | 2021 | |
| Abbvie INC. | $82.68 | 2022 | |
| Sk Life Science, INC. | $79.88 | 2020-2023 | Xcopri |
| Emd Serono, INC. | $75.71 | 2019 | |
| Genentech, INC. | $73.30 | 2023 | Ocrevus |
| Eisai INC. | $57.66 | 2024 | |
| Lilly USA, LLC | $57.58 | 2024 | Kisunla |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $54.55 | 2020-2022 | |
| Argenx US, INC. | $35.95 | 2023 | Vyvgart |
| Celgene Corporation | $25.93 | 2020 | |
| Livanova USA, INC. | $15.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Moll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.